Chemical-induced skin cancer in mice has been operationally separated into three chronological stages term initiation, promoInstitute of Chemical Toxicology, Wayne State University, Detroit, tion and progression (1). In turn, each of these stages appears MI 48201, USA to involve numerous interactive processes. Pharmacological 1 To whom correspondence should be addressed approaches and comparative analyses of genetically engineered Embryonic stem cells derived from various derivatives of mice have implicated a variety of genes as playing some role the murine 129/J strain are commonly used in the generain these processes. Indeed, recent analyses of p53 null mice tion of knockout mice. Topical twice-weekly treatment of demonstrate the usefulness of the knockout approach in the 129/SvEv subline with either 2 or 5 µg of 12-Oassessing the role of a specific gene product in the ontogeny tetradecanoylphorbol-13-acetate (TPA) for 4 weeks resulted of chemical-induced skin cancer (2). However, although the in a sustained inflammation and hyperplasia. Identically knockout approach has tremendous power, it has one not so treated C57BL/6 mice developed weaker inflammatory and obvious limitation with respect to the study of the mechanism hyperplastic responses over the same treatment course, of tumor promoters. Specifically, susceptibility to promotion and did not exhibit a sustained hyperplasia. SSIN mice varies markedly in different strains and stocks of mice (3-7). treated with either 0.5 or 2 µg of TPA developed a sustained Furthermore, the crossing of susceptible and resistant mice hyperplasia comparable to that seen in 129/SvEv mice, but often results in hybrid progeny that are unlike either parent in a weak inflammatory response. Myeloperoxidase (MPO) their response to phorbol esters (7). The development of measurements indicated dramatic infiltrations of the skins knockout mice requires a productive breeding of the chimerics of all three murine strains by neutrophils within 48 h of a with non chimeric mice. Progeny derived from the breeding single TPA application. MPO activities remained signiof a chimeric with the strain from which the ES cells were ficantly elevated in the skins of 129/SvEv mice and derived, and having the mutated allele, have the genetic C57BL/6 mice following eight TPA treatments. In contrast, background of the ES cells. In contrast, the breeding of MPO activities in 8ϫtreated SSIN skins were comparable chimerics with any strain of mouse other than that from which to those measured in solvent controls. 129/SvEv mice the ES cells were derived results in a hybrid mouse. Such readily developed papillomas in two-stage skin carcinomice may differ from their parents in their susceptibility to genesis protocols employing DMBA as the initiator and tumor promoters because of their hybrid nature, as opposed TPA as the promoter. Papilloma incidences and multiplito a genetically engineered gene deletion or inactivation. cities were dose-responsive with respect to promoter (using Hence, the least complicated approach to generate non-hybrid twice weekly applications of 1, 2 or 5 µg of TPA). With a knockout mice is to breed chimeric mice with the strain from promoting dose of 5 µg of TPA ജ90% of the mice developed which the ES cells were derived and select those mice having papillomas within 13 weeks, and maximum tumor multiplithe mutated allele. cities were reached within 18 weeks. These latter results, Most of the knockout mice generated to date have been when compared to the published responses of other murine derived from a very limited number of ES cell lines. Many of stocks and strains, demonstrate that 129/SvEv mice are very the more commonly used ES lines have been derived from sensitive to TPA promotion in two-stage skin carcinogenesis sublines of the 129/J mouse (8). This is an agouti coat-colored protocols.
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murine strain whose susceptibility to complete and two-stage carcinogenesis has yet to be reported. In this study we used analyses of cutaneous hyperplasia, edema, and myeloRecent advances in genetic engineering have provided powerful peroxidase (MPO) activity to estimate the development and approaches to assess the cellular function of specific gene sustained responsiveness of 129/SvEv mice, a subline of the products. One such approach entails the study of mice in 129/J strain, to varying doses of topically applied TPA. which one or both alleles of a gene are absent or rendered These three parameters are commonly employed to measure inactive. The derivation of such 'knockout' mice requires responsiveness to TPA, and the ability to maintain a sustained pluripotent embryonic stem cells (ES*) and entails several hyperplasia following chronic TPA treatment has been shown steps including: modification of the target allele in cultured to be a good prognosticator of responsiveness in two-stage ES cells; selection of the modified ES cells and their injection carcinogenesis protocols (4, 9) . We also included parallel into blastocysts; implantation of the blastocysts into surrogate analyses of C57BL/6 and SSIN mice in order to gauge the dames; and breeding of chimeric offspring with other mice to responsiveness of the 129/SvEv mice to TPA. DMBA-initiated assess germ line transmission. Progeny resulting from success-C57BL/6 mice develop few tumors in two-stage carcinogenesis ful germ line transmission are generally mated in order to protocols employing twice weekly applications of 2-5 µg of expand their numbers and/or produce homozygous nulls.
TPA (5, 7) . In contrast, DMBA-initiated SSIN mice rapidly develop skin tumors following twice weekly applications of SSIN mice, 5-6 weeks old, were purchased from the Science Park-Veterinary Division, The University of Texas Bradley et al. (11) was used to quantitate MPO activities in supernatant fluids. This is a coupled assay that monitors MD Anderson Cancer Center (Bastrop, TX). Female C57BL/ 6 and 129/SvEv mice were purchased from the National Cancer the oxidation of o-dianisidine at 460 nm (E ϭ 1.13ϫ10 4 M -1 cm -1 ) to indirectly quantitate hydrogen peroxide concentraInstitute (Frederick, MD) and Taconic (Germantown, NY), respectively. Mice were housed in microisolator cages and tions. One unit of MPO is the amount of enzyme capable of degrading 1 µmol of H 2 O 2 per minute at room temperature. maintained on a 12 h light:12 h dark photocycle. They were quarantined for a minimum of one week before the initiation MPO activities in skin were normalized to reflect total units present in a 1 cm 2 punch. of any treatments. Food and water were provided ad libitum.
Studies intended to investigate the effects of TPA on The epidermis of the non treated 129/SvEv mouse, like other murine strains, was devoid of a true spinous layer epidermal hyperplasia, edema and MPO activities employed a protocol in which the dorsal trunks of 7-8 week old mice ( Figure 1A ). It was basically unaffected by one, four or eight applications of acetone ( Figure 1B , C, and D, respectively). were shaved with surgical clippers 2-4 days prior to topical application of 200 µl of acetone, or TPA dissolved in acetone.
In contrast, a significant epidermal hyperplasia developed within 48 h of a single application of either 2 µg ( Figure 1E ) Treated mice were killed by cervical dislocation 44-48 h after the last topical treatment. After removal of regrown hair by or 5 µg ( Figure 1F ) of TPA. The hyperplastic response became even more pronounced after four ( Figure 1G ) and eight (Figure shaving, the dorsal skin was excised and stretched on an index card. Strips of skin were removed for fixation and subsequent 1H) applications of 2 µg of TPA. A quantitative analysis of the epidermal hyperplasia induced by 2 µg and 5 µg TPA is histological analyses. Three circular (8 mm diameter) punches of the pelts were weighed after removal of the adhering paper.
presented in Figure 2A . The two doses had quite similar effects over the course of treatment. Furthermore, chronic treatment Each punch was transferred to a tube containing 1.5 ml of 50 mM phosphate buffer, pH 6.0, and 0.5% hexadecyltriwith TPA supported a sustained epidermal hyperplasia. The epidermal hyperplasia induced in 129/SvEv mice by methylammonium bromide. Tissues were homogenized with a Polytron (3ϫ10 s, setting 5) and then centrifuged for 10 min TPA was accompanied by increases in skin weights and inflammatory cell content. Skin weights were significantly at 11 000 g. The resulting supernatant fluids were split into multiple samples and stored at -20°C. An assay described by increased within 48 h of a single application of 2 µg or 5 µg Figure 2D ) and elevated skin weights ( Figure 2E ), and MPO 2B). The development of edema (very obvious after the first treatment) and increases in the cellularity of both the epidermis activities ( Figure 2F ). However, there was at least one obvious difference between the two strains. Specifically, the hyperand dermis probably contributed to these weight changes. Of particular note were the dramatic increases in dermal neutrophil plastic response in C57BL/6 mice neither approached the magnitude of that seen in 129/SvEv mice, nor was it sustained content following TPA treatment (compare upper with lower panels in Figure 1 ). With respect to the treatment schedule, it following repeated applications (compare Figure 2A with D) . This inability to maintain a sustained hyperplastic response appeared that neutrophil levels reached a maximum after four exposures to TPA, and then declined (compare Figure 1E , G following chronic TPA application has been noted by others (12), and implicated as a basis for this strain being refractory and H). This interpretation of the histological data is supported by analyses of skin MPO activities, an enzyme characteristic to promotion by twice weekly applications of TPA (4). Dose-response studies have identified the SSIN mouse as of polymorphonuclear leukocytes (11). MPO activities were dramatically elevated following a single TPA application, being extraordinarily sensitive to TPA promotion in two-stage carcinogenesis protocols. Analyses of short term parameters peaked after four treatments, and declined to ഛ 65% of their peak activity by the eighth treatment ( Figure 2C ).
in SSIN mice were performed following the application of either 0.5 or 2 µg of TPA. The lower dose is a potent, The responses of C57BL/6 mice to TPA treatment were somewhat similar to those noted in 129/SvEv mice. Single and but suboptimal promoting dose in two-stage carcinogenesis protocols; whereas, the upper dose may be at, or slightly greater than the optimal promoting dose (10). Like 129/SvEv mice, topical treatment of SSIN mice with TPA lead to a profound and sustained epidermal hyperplasia ( Figure 2G ). TPA treatment also lead to small increases in skin weights ( Figure 2H ) comparable to those reported by other investigators (13). A single application of TPA also significantly elevated cutaneous MPO activity ( Figure 2I ). Unanticipated was the observation that MPO activities dramatically dropped between the first and fourth TPA treatment ( Figure 2I ). Histological examination of tissue sections corroborated the relative absence of an inflammatory response in SSIN mice treated 8ϫwith TPA (unpublished data). The significance of this drop to the processes of tumor promotion and progression is speculative. Studies have appeared which discount the need for inflammation in the promotion process (7, 13) . However, inflammation is thought to produce highly reactive species capable of The development and maintenance of a sustained hyperplasia following repetitive TPA treatment suggested that the 129/ SvEv mouse may be responsive in two-stage carcinogenesis development was dependent upon the mice being initiated prior to TPA treatment. A second independent experiment using a higher initiating dose of DMBA (100 nmol) corroborated An unexpected result of the tumor studies was the finding that a 5-fold difference in initiating dose had little effect on the results obtained in the first study ( Figure 3C and D) . Furthermore, the lack of tumor development in mice initiated papilloma multiplicites at comparable doses of TPA (compare Figure 3B with D). Tumor multiplicites, at fixed doses of with DMBA and promoted with acetone demonstrated that a single application of 100 nmol of DMBA did not constitute a promoter, generally increase with increasing doses of initiator in two-stage carcinogenesis protocols. DMBA must be metacomplete carcinogenic dose in 129/SvEv mice ( Figure 3C and D).
bolized in order to function as an initiator. This metabolic activation is mediated by P450s CYP1A1 and CYP1B1. Both Most of the papillomas that developed in two-stage carcinogenesis protocols did not regress ( Figure 3B and D) . (Table I) . However, a large number of animals parental background for the 129/SvEv strain, have the Ah d allele (20). Hence, our observed tumor data may reflect a appeared to be without SCC, and the overall conversion of papillomas to SCC was very modest (Table I, Figure 3B and D to TPA promotion than SSIN and SENCAR mice, but more 
